Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Furanoditerpenes from Pterodon pubescens benth with selective in vitro anticancer activity for prostate cell line

Full text
Author(s):
Spindola, Humberto M. [1, 2] ; de Carvalho, Joao E. [1, 2] ; Ruiz, Ana Lucia T. G. [1] ; Rodrigues, Rodney A. F. [1] ; Denny, Carina [1, 2] ; de Oliveira Sousa, Ilza M. [1] ; Tamashiro, Jorge Y. [3] ; Foglio, Mary Ann [1, 2]
Total Authors: 8
Affiliation:
[1] Univ Estadual Campinas, CPQBA, BR-13083970 Campinas, SP - Brazil
[2] Univ Estadual Campinas, Fac Odontol, Dept Farmacol Anestesiol & Terapeut, BR-13414903 Piracicaba, SP - Brazil
[3] Univ Estadual Campinas, Inst Biol, BR-13083970 Campinas, SP - Brazil
Total Affiliations: 3
Document type: Journal article
Source: Journal of the Brazilian Chemical Society; v. 20, n. 3, p. 569-U241, 2009.
Web of Science Citations: 27
Abstract

Activity guided fractionation of Pterodon pubescens Benth. methylene chloride-soluble fraction afforded novel 6α-acetoxi 7β-hydroxy-vouacapan 1 and four known diterpene furans 2, 3, 4, 5. The compounds were evaluated for in vitro cytotoxic activities against human normal cells and tumour cell lines UACC-62 (melanoma), MCF-7 (breast), NCI-H460 (lung, non-small cells), OVCAR-03 (ovarian), PC-3 (prostate), HT-29 (colon), 786-0 (renal), K562 (leukemia) and NCI-ADR/RES (ovarian expressing phenotype multiple drugs resistance). Results were expressed by three concentration dependent parameters GI50 (concentration that produces 50% growth inhibition), TGI (concentration that produces total growth inhibition or cytostatic effect) and LC50 (concentration that produces -50% growth, a cytotoxicity parameter). Also, in vitro cytotoxicity was evaluated against 3T3 cell line (mouse embryonic fibroblasts). Antiproliferative properties of compounds 1, 4 and 5 are herein reported for the first time. These compounds showed selectivity in a concentration-dependent way against human PC-3. Compound 1 demonstrated selectivity 26 fold more potent than the positive control, doxorubicin, for PC-3 (prostrate) cell line based on GI50 values, causing cytostatic effect (TGI value) at a concentration fifteen times less than positive control. Moreover comparison of 50% lethal concentration (LC50 value) with positive control (doxorubicin) suggested that compound 1 was less toxic. (AU)